" class="no-js "lang="en-US"> Cell therapy Archives - Medtech Alert
Friday, April 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Mendus and NorthX Biologics to Enter into Strategic Cell Therapy Manufacturing Alliance Supported by New Investor Flerie

Mendus AB, a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it […]

BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

BioCentriq, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today […]

Gamida Cell Appoints Terry Coelho as CFO

Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]

Cellular Origins Partners with ScaleReady to Simplify, Standardise, and Automate Cell Therapy Manufacturing

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell […]

Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval

Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, today announced […]

Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced […]

Legend Biotech Announces Appointment of Chief Medical Officer

Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening […]

CTRL Therapeutics Launches with $10M Seed Financing to Advance Next-Generation Cell Therapy Platform for the Treatment of Solid Tumors

CTRL Therapeutics, a biotechnology company developing a next-generation cell therapy platform for solid tumors, has […]

Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform

Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has […]

BlueRock Therapeutics to use Rune Labs' Clinical Trial Platform to Better Characterize Parkinson's Disease State in Cell Therapy Trials

Rune Labs, a precision neurology software and data platform company, today announced a partnership with […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more